Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Mini
Stefania Nobili

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
"Pharmacogenetics of Cancer" - <i>Cancer Drug Resistance</i> special issueEnrico Mini, Stefania Nobili
Journal of Personalized Medicine|March 25, 2022
Special Issue: "Gastrointestinal Cancers and Personalized Medicine"Stefania Nobili, Enrico Mini
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Pharmacogenetics: implementing personalized medicineEnrico Mini, Stefania Nobili
Journal of Chemotherapy (Florence, Italy)|August 22, 2019
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical developmentGiandomenico Roviello, Stefania Nobili, Enrico Mini
Frontiers in Oncology|June 2, 2015
Editorial: multidrug resistance in cancer: pharmacological strategies from basic research to clinical issuesChiara Riganti, Enrico Mini, Stefania Nobili
Medicinal Research Reviews|March 5, 2011
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expressionStefania Nobili, Ida Landini, Teresita Mazzei, et al.
Journal of Oncology|July 14, 2020
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line TreatmentGiandomenico Roviello, Andrea Casadei-Gardini, Stefania Nobili, et al.
Pharmacology & Therapeutics|June 27, 2021
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challengeDaniele Lavacchi, Ida Landini, Gabriele Perrone, et al.
International Journal of Molecular Sciences|October 29, 2020
Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?Giandomenico Roviello, Martina Catalano, Stefania Nobili, et al.
Seminars in Cancer Biology|August 15, 2019
Role of ATP-binding cassette transporters in cancer initiation and progressionStefania Nobili, Andrea Lapucci, Ida Landini, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
"Pharmacogenetics of Cancer" - <i>Cancer Drug Resistance</i> special issueEnrico Mini, Stefania Nobili
Journal of Personalized Medicine|March 25, 2022
Special Issue: "Gastrointestinal Cancers and Personalized Medicine"Stefania Nobili, Enrico Mini
Clinical Cases in Mineral and Bone Metabolism : the Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases|March 31, 2012
Pharmacogenetics: implementing personalized medicineEnrico Mini, Stefania Nobili
Journal of Chemotherapy (Florence, Italy)|August 22, 2019
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical developmentGiandomenico Roviello, Stefania Nobili, Enrico Mini
Frontiers in Oncology|June 2, 2015
Editorial: multidrug resistance in cancer: pharmacological strategies from basic research to clinical issuesChiara Riganti, Enrico Mini, Stefania Nobili
Medicinal Research Reviews|March 5, 2011
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expressionStefania Nobili, Ida Landini, Teresita Mazzei, et al.
Journal of Oncology|July 14, 2020
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line TreatmentGiandomenico Roviello, Andrea Casadei-Gardini, Stefania Nobili, et al.
Pharmacology & Therapeutics|June 27, 2021
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challengeDaniele Lavacchi, Ida Landini, Gabriele Perrone, et al.
International Journal of Molecular Sciences|October 29, 2020
Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?Giandomenico Roviello, Martina Catalano, Stefania Nobili, et al.
Seminars in Cancer Biology|August 15, 2019
Role of ATP-binding cassette transporters in cancer initiation and progressionStefania Nobili, Andrea Lapucci, Ida Landini, et al.
Pageof 15